CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash flows from operating activities
Net income (loss)	$ 2,390,251	$ (5,068,995)
Adjustments to reconcile net loss to cash provided by (used in) operating activities
Stock based compensation expense	163,269	143,063
Depreciation and amortization	1,634,547	1,737,013
Gain on sale of assets	0	(2,293)
Bad debt and reduction in allowance for bad debt	23,925	(303,796)
(Decrease) increase in fair value of derivative warrant liability	(1,698,747)	1,705,094
(Gain) Loss on commodity derivative contracts	(4,427,782)	759,767
Net cash settlements on commodity derivatives	4,507,370	(657,577)
Amortization of debt discount and deferred costs	47,826	143,477
Changes in operating assets and liabilities
Accounts receivable	2,260,654	(4,375,379)
Inventory	2,112,459	1,820,641
Prepaid expenses	1,061,222	1,173,298
Accounts payable	(1,603,145)	1,359,493
Accrued expenses	(3,269,590)	(408,686)
Other assets	(87,251)	(2,000)
Net cash provided by (used in) operating activities	3,115,008	(1,976,880)
Cash flows from investing activities
Internally developed software	(49,229)	0
Purchase of fixed assets	(442,180)	(774,897)
Proceeds from sale of fixed assets	0	10,000
Net cash used in investing activities	(491,409)	(764,897)
Cash flows from financing activities
Payments on finance leases	(53,119)	(23,382)
Contributions received from redeemable noncontrolling interest	21,000,000	0
Line of credit (payments) proceeds, net	(3,276,230)	2,525,874
Proceeds from note payable	0	187,501
Payments on note payable	(8,098,879)	(1,021,239)
Net cash provided by financing activities	9,571,772	1,668,754
Net change in cash, cash equivalents and restricted cash	12,195,371	(1,073,023)
Cash, cash equivalents, and restricted cash at beginning of the period	4,199,825	2,849,831
Cash, cash equivalents, and restricted cash at end of period	16,395,196	1,776,808
SUPPLEMENTAL INFORMATION
Cash paid for interest	352,806	602,732
Cash paid for taxes	0	0
NON-CASH INVESTING AND FINANCING TRANSACTIONS
Accretion of discount on Series B and B1 Preferred Stock	932,003	560,675
Dividends-in-kind accrued on Series B and B1 Preferred Stock	344,499	406,795
Initial adjustment of carrying amount redeemable noncontrolling interest	9,091,068	0
Accretion of redeemable noncontrolling interest to redemption value	10,966,349	0
Series B1 Preferred Stock
NON-CASH INVESTING AND FINANCING TRANSACTIONS
Conversion of Series B1 Preferred Stock into common stock	3,368,474	$ 150,010
Dividends-in-kind accrued on Series B and B1 Preferred Stock	$ 163,908